P-175: Kallikrein-kinin, nitric oxide and renalvascular regulation after acute protein challenge in obese hypertensive patients

Previous studies have demonstrated the role of renal kallikrein (rKal), vasoactive kinins and nitric oxide (NO) in regulating the renal response to acute oral protein load (renal reserve, RR). The aim of this study was to evaluate the effects of protein load on renal hemodynamics of obese hypertensi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of hypertension 2001-04, Vol.14 (S1), p.88A-88A
Hauptverfasser: Pecly, I. M. D, Genelhu-Fagundes, V., Barroso, S. G., Rodrigues, M. L. G, Duarte, A. V. B, Garcia, F. L., Boasquevisque, E., Francischetti, E. A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Previous studies have demonstrated the role of renal kallikrein (rKal), vasoactive kinins and nitric oxide (NO) in regulating the renal response to acute oral protein load (renal reserve, RR). The aim of this study was to evaluate the effects of protein load on renal hemodynamics of obese hypertensive patients and the possible participation of rKal and NO in this response. We studied 14 obese hypertensive patients, (BMI: 32.9 ± 1.1, age: 50.5 ± 0.9 yrs, SBP: 153.5 ± 2.8 mmHg, DBP:96.2 ± 2.2 mmHg, 5 males and 9 females). Hemodynamic and metabolic evaluations were conducted at basal condition and after protein challenge moment (1g/kg of weight). Glomerular filtration rate (GFR) was estimated by clearance of inulin, and renal plasma flow (RPF) was calculated by the clearance of 131 orthoiodohippurate. We measured the levels of plasmatic and urinary NO by the Griess reaction modified, and the urinary excretion of rKal by chromogenic substrate. The mean RR of the patients was 8.0 ± 1.1. After protein load there was a significant increase of urinary kal (0.12 ± 0.04 vs 0.29 ± 0.06 Kal/Cr, p = 0.002), plasma NO (22.1 ± 0.8 vs 25.8 ± 2.1 μM, p = 0.04), RPF (374.2 ± 25.5 vs 438.8 ± 27.2 ml/min, p = 0.02) and GFR (143.7 ± 7.8 vs 151.7 ± 7.0 ml/min, p = 0.0009), but no difference was observed in the urinary concentration of NO. We concluded that in obese hypertensive individuals, the vasodilator capacity of renal vasculature after protein load is preserved and may be mediated by renal kallikrein and NO.
ISSN:0895-7061
1941-7225
1879-1905
DOI:10.1016/S0895-7061(01)01820-9